Smoking cessation Felix K. Karthik.

Slides:



Advertisements
Similar presentations
Encouraging cessation intervention to become routine practice for people working with Aboriginal and Torres Strait Islander clients Toni Mason Aboriginal.
Advertisements

Quitting smoking is always the best option, however, some smokers are not yet ready or willing to quit and continue to inflict harm on themselves and the.
Smoking and mental health Mark Allen Specialist Health Improvement Practitioner.
Inaugural Research Seminar Point of sale displays and beyond: The next steps for tobacco control in retail settings.
Quit Information Seminar. Aims of session To: help you to understand why people smoke provide information about quitting methods and products discuss.
Key Public Health issues of smoking Passive smoking in home, car, workplace, restaurants etc. Self- induced disease and cost of smoking related diseases.
* Imagine that everyone in this room is a smoker. * Half go to one side * Half go to the other * What do you think this represents?
Nicotine Replacement Therapy: Administration and Overview Barbara Hart, MPA and Claudia Lechuga, MS Bronx BREATHES T: (718) E:
Prevention strategies
Smoking Cessation. Opportunity for Physicians 70 percent of smokers want to quit. Without assistance only 5 percent are able to quit. Most try to quit.
Treating Nicotine Dependence in Patients with Addictive Disorders Eric Heiligenstein, M.D. Director of Psychiatry University Health Services University.
Smoking cessation in New Zealand
Smoking Cessation Its place in Tobacco Control
Nancy Rigotti, MD Treatment Review: Overview of the Evidence Base for Tobacco Dependence Treatment 10/09/2011.
TOBACCO. Tobacco & Youth  “Each day in the U.S., approximately 4,000 adolescents aged try their first cigarette.”  (CDC, 2008)  Approximately.
Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)
What we need to know about smoking & tobacco addiction.
Quit Information Seminar. Aims of session To: help you to understand why people smoke provide information about quitting methods and products discuss.
Tobacco harm reduction: NICE guidance and recent developments Linda Bauld.
Real-world effectiveness of nicotine replacement therapy in pregnancy Leonie S. Brose, PhD Andy McEwen, PhD & Robert West, PhD University College London.
Clinical trial 2. Objective To evaluate efficacy and safety of varenicline for smoking cessation compared with sustained-release bupropion (bupropion.
The Last Kiss An Internist’s Look at Smoking Cessation AIMGP 2007 Ken Locke MD, FRCPC.
1 Smoking Cessation: What works and why… A Medical Model Stephen I Rennard University of Nebraska Florianopolis, Brazil October 2009.
Laws/Policies ABSTRACT Problem: A challenge for tobacco control practitioners is getting smokers to quit using cessation methods. To increase the proportion.
Increasing Access to Pharmacotherapy Jonathan P. Winickoff, MD, MPH Associate Professor in Pediatrics Harvard Medical School April 26, 2013.
Nicotine dependence It’s in ICD 10! MRCPsych addiction psychiatry seminars March 2010.
Prepared by: Dr. Mohammad Shaikhani University of Sulaimani College of Medicine. Dept of Medicine.
Clinical trial 2. Objective To evaluate efficacy and safety of varenicline for smoking cessation compared with sustained-release bupropion (bupropion.
Effects of a combination of varenicline and nicotine patch on post-quitting urges to smoke Katie Myers Smith BSc MSc CPsychol Research Fellow Wolfson Institute.
Attempting to increase the use of smoking cessation medications Brendon Baker Ministry of Health.
Quitting smoking is always the best option however, some smokers are not yet ready or willing to quit and continue to inflict harm on themselves and the.
1 Varenicline for smoking cessation Robert West University College London Logroño, October
1 Why do people smoke when they know it’s bad for them? University College London November 2013 Robert West some.
1 Recent studies of clinical significance University College London June 2011 Robert West.
Addressing Tobacco Use in Mental Health Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester.
1 Advising smokers on optimum pharmacotherapy for smoking cessation University College London April 2014 Robert West.
Addressing Tobacco Use in Medical Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester School.
1 A national initiative to help smokers quit: the English experience Robert West University College London Stockholm, April 2008.
1 What can the experience of combatting tobacco addiction tell us about better ways of addressing other addictions? University College London March 2014.
1 Products for smoking cessation University College London March 2014 Robert West.
1 Cytisine for smoking cessation Robert West John Stapleton Magda Cedzynska Paul Aveyard Witold Zatonski.
1 Smoking and health University College London 2010 Robert West.
1 What if anything to do about smoking and oral tobacco use in your patients University College London October 2013 Robert West.
1 Identifying affordable, practicable and effective clinical interventions to promote smoking cessation University College London February 2013 Robert.
Smoking. Why people smoke and find it difficult to stop Smoking is an addictive habit. It is associated with strong cravings, dependency, tolerance, and.
Hot topics in smoking cessation Robert West University College robertjwest 1.
1 Cigarette addiction: a psychological perspective University College London June 2009 Robert West.
1 Should behavioural support for smoking cessation address wider psychological problems? University College London October 2013 Robert West.
Smoking Cessation Medication
6 myths and facts about tobacco use disorder in people with mental health and substance use disorders Associate Professor.
screening, brief intervention, and referral to treatment
FDA Authority to Regulate Tobacco Products Tobacco Control Act
Smoking and smoking cessation in the real world
Why and How to Quit Smoking
Robert West University College London WCTOH Washington 2006
Stop Smoking Wales support Daniel Clayton – Health Promotion Practitioner Insert name of presentation on Master Slide V: 01/2012.
Robert West University College London London March 2008
Behavioural and pharmacological approaches to treating smokers
Forming a Tobacco Addiction
Nicotine replacement therapy
Latest trends on smoking in England from the Smoking Toolkit Study
ABCs of Behavioral Support
Pathways to Quit: Options for Smoking Cessation Strategies
Smoke-free policy Duke University will be a smoke-free campus beginning July 1, This means the use of all combustible tobacco products (tobacco.
Tobacco.
Understanding the impact of the recession on smoking
Tobacco Addiction & The CURE Project
Tobacco.
Tobacco.
Presentation transcript:

Smoking cessation Felix K. Karthik

Why smoking is addictive? Positive reinforcment Increase in dopamine Binds to nACh receptors NICOTINE

Tobacco Withdrawal symptoms

SMOKERS DIE EARLY! Pirie et al Lancet. 2013 Jan 12;381(9861):133-41

Making a quit attempt Tensions and triggers Tension Triggers Price Health concerns Triggers Sudden illness Price rise Advice from a health professional

Remaining quit

Importance of brief advice Stead et al 2013. Physician advice for smoking cessation. Cochrane Database of Systematic Reviews. CD: 000165

Getting over the initial withdrawal discomfort Behavioural support is of proven efficacy Can be delivered in different formats Face-to-face (individual or group) Telephone Internet Pharma intervention: NRT (nicotine replacement therapy), bupropion (Zyban), nortriptyline and varenicline (Chantix) are of proven efficacy

Nicotine Delivery

Bupropion

Varenicline (CHANTIX) Varenicline works by reducing craving for cigarettes making quitting smoking a little easier and increases the chances of stopping for good. However it’s no magic cure and effort is still required.

SAFETY AND SIDE EFFECTS -CHANTIX Nausea (30%) – mostly well tolerated Strange dreams, headache, flatulence, and insomnia Serious mood and cardiovascular adverse events

E-Cigarettes How many have tried E-cigarettes?

Components of E-cigarettes

Fluid contains…..

“Harmless” Vapor

Recent FDA measures Push tobacco industry to make cigarettes with less nicotine to make them less addictive Banning sales of e –cigarettes to kids age <18 years FDA carefully weighing still the opportunity for e-cigarettes as potentially low risk alternative to smokers All e-cigarettes including the components of e-cigarettes will be regulated by FDA in the coming years to make it safe!

Finally…… GOOD LUCK! THANK YOU!!!!!